Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor

BACKGROUND: We aimed to establish a prognostic model to identify suitable candidates for chemotherapy combination PD-1 inhibitor in metastatic nasopharyngeal carcinoma (NPC) patients. PATIENTS AND METHODS: In this retrospective study, we included 524 patients (192 patients treated with chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guo-Ying, Lu, Nian, Bei, Wei-Xin, Li, Wang-Zhong, Liang, Hu, Xia, Wei-Xiong, Xiang, Yan-Qun, Yao, He-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887186/
https://www.ncbi.nlm.nih.gov/pubmed/36733479
http://dx.doi.org/10.3389/fimmu.2023.1069010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887186/
https://www.ncbi.nlm.nih.gov/pubmed/36733479
http://dx.doi.org/10.3389/fimmu.2023.1069010

Ejemplares similares